Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73

Published:2024-05-29 Issue:11 Volume:67 Page:9686-9708
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shi Cunjian¹,Chang Longfeng¹,Wang Jie¹,Dai Jingqi¹,Xu Wenyue¹,Tang Jiangyang¹,Mei Wenyi¹,Zhang Chen¹,Wang Zedong¹,Liao Yichen¹,Zhang Xingsen¹,Jiang Wenzhe¹,Zhang Guozhen¹,Zhao Zhenjiang¹,Xu Yufang¹^ORCID,Zhu Lili¹^ORCID,Li Honglin¹²³^ORCID

Affiliation:

1. Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China

2. Innovation Center for AI and Drug Discovery, East China Normal University, Shanghai 200062, China

3. Lingang Laboratory, Shanghai 200031, China

Funder

National Key Research and Development Program of China

National Program for Support of Top-notch Young Professionals

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00825

Reference35 articles.

1. The adenosine pathway in immuno-oncology

2. Targeting Cancer-Derived Adenosine:New Therapeutic Approaches

3. Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling

4. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39

5. Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3